Treatment of Psoriasis With Parathyroid Hormone

Completed · Phase 1/Phase 2

Conditions studied: Plaque Psoriasis

In brief

This is a clinical study in two phases. The first phase compares the effect of an ointment containing parathyroid hormone (PTH) with the effect of a placebo ointment (inactive ointment without PTH) on psoriasis lesions. Neither the study participants nor the researchers will know who is receiving PTH ointment and who is receiving placebo until the end of this first study phase. The second phase is a study of the PTH ointment on large areas of psoriasis to find out how long the effects last.

Key facts

Study ID

NCT00007306

Run by

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

People needed

40

Starts

2000-01-01

Expected to finish

2005-04-01

Last updated by the study team

2007-01-04

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Active plaque psoriasis at least 10 percent BSA (body surface area)
• Age 18-70

You may not qualify if…

• Abnormalities of calcium metabolism

Where it is running

• Boston University School of Medicine — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.